Japan, Aug. 12 -- IDORSIA PHARMACEUTICALS LTD has got intellectual property rights for 'SUBCUTANEOUS ADMINISTRATION OF P2Y12 RECEPTOR ANTAGONIST.' Other related details are as follows:

Application Number: JP,2024-230902

Category (FI): A61P9/10,A61P43/00,111,A61P7/02,A61K31/675,A61K31/506

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 26, 2024

Publication Date: April 10, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....